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Medical conditions in children with Down syndrome: a 
literature review 
Background: Children with Down syndrome experience an array of medical conditions 
and health care problems. Although there have been vast improvements in the medical 
management of these conditions, they still significantly impact on quality of life for 
families and children with Down syndrome. However, despite the magnitude of this 
problem limited literature has described the overall health status of children with Down 
syndrome. 
Aim: The purpose of this review was to describe the medical conditions commonly 
experienced by children with Down syndrome and to consider the clinical implications of 
this knowledge. 
Methods: Databases Medline, CINHAL and PsychiNFO were electronically searched to 
identify relevant articles from 1990 to 2009. Inclusion criteria were children aged 18 
years or younger with a diagnosis of Down syndrome, who had one or more medical co-
morbidity. Articles were excluded at the title or abstract level if they were not peer 
reviewed, English articles, or did not meet the inclusion criteria. A narrative review of 
this research was possible. 
Results: Common medical conditions experienced by children with Down syndrome 
include: cardiac and gastrointestinal disorders, musculoskeletal disorders, respiratory 
problems, eye and visual defeCts, ear and hearing impairments, frequent episodic illnesses 
and infections, and a greater risk of leukaemia and thyroid conditions. Prevalence 
estimates for these conditions varied depending on the diagnostic criteria or study 
methodologies. 
Conclusion: Knowledge of the high levels of co-morbidities experienced by children 
with Down syndrome will lead to the development of more effective interventions for 
teachers and health care professionals, and also assist in the provision and resource 
allocation of disability services. 
Author: Kelly Thomas 
Supervisors: Dr Sonya Girdler, 
Dr Helen Leonard and Ms Jenny Bourke 
Submission date: August, 2009 
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Medical conditions in children with Down syndrome: a 
literature review 
Introduction 
~---, 
Down syndrome is a chromosomal birth disorder and the single most common cause of 
intellectual disability in Western Australia [1]. The worldwide prevalence of Down 
syndrome varies and may be determined by accessibility to prenatal screening [2], socio-
cultural attitudes, religious beliefs and political legislation regarding termination of 
pregnancy [3]. In Western Australia since 1980, the number of children born with Down 
syndrome has remained relatively stable at approximately 1 per 1000 births, however the 
overall cases of Down syndrome conceptions (live births, still births and terminations of 
pregnancy) has more than doubled, from 1.2 per 1000 conceptions in 1980-84, to 2.6 per 
1000 in 2006 [4]. This change in the epidemiology of Down syndrome has been largely 
the result of increasing maternal age [5] and the widespread utilisation of early prenatal 
screening [6]. 
It is well documented that Down syndrome is strongly correlated with maternal age [7]. 
Due to the changing roles of women in westernised societies, major socio-demographic 
shifts have resulted in increasing maternal age. Within the Australian context, women's 
participation in the workforce has increased from 40% in 1979 to 55% in 2006 [8, 9] and 
their educational attainment is now similar to that of men [10]. As a result, the 
postponement of childbirth has contributed to the overall increase in Down syndrome 
conceptions [4]. 
The large increase in the reporting of Down syndrome conceptions is attributed to the 
accessibility and utilisation of antenatal screening programs. In Australia, since 1999, the 
rate of women's participation in antenatal screening programs has increased 2.5 fold to 
44% [11] and the proportion of Down syndrome cases diagnosed prenatally for women 
under 35 has increased from 3% to 60% [12]. As a result, foetuses which would usually 
have spontaneously miscarried, are now being detected, contributing to an increase in the 
reporting of Down syndrome conceptions [12, 13]. However, a corresponding increase in 
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terminations of Down syndrome pregnancies has resulted in a relatively stable prevalence 
of Down syndrome live births [14]. Rates of terminations are however influenced by 
countries' differing legislation regarding termination of pregnancy and their societies 
socio-cultural beliefs [3]. 
Developed countries have seen dramatic improvements in infant survival and overall life 
expectancy for people with Down syndrome. In Australia over the past 40 years, the 
average life expectancy of people with Down syndrome has increased from 18 to 60 
years of age [14]. Of particular significance is the improvement in infant survival 
whereby 91% of infants are expected to survive to one year, and 85% to ten years [15]. 
These rates are comparable to other developed countries [16, 17]. Internationally, there 
are ethnic disparities associated with infant survival with American research reporting 
black maternal race having a seven -fold increase in the risk of infant mortality, but only 
among infants without cardiac defects [16]. Within Australia, survival of Aboriginal 
children with Down syndrome is also significantly reduced compared to non-Aboriginal 
children [15]. 
Several factors have contributed to improvements in the survival rates for children with 
Down syndrome. The most important of these has been surgical advances in the 
management of congenital heart disease [17]. In addition, improved accessibility to 
antibiotics and vaccinations have contributed to a decline in morbidity and improved life 
expectancy of people with Down syndrome [14]. Changes in community and health 
professionals' attitudes have also influenced health care accessibility and survival [14], 
whereby people with Down syndrome are now afforded a higher degree of equality in the 
health care system [18]. However, ethical debates still persist in relation to implementing 
policies of equality when accounting for limited resources [18]. 
Children with Down syndrome experience an array of medical conditions and health care 
problems which have been widely documented. Although there have been vast 
improvements in the medical management of these conditions leading to increased rates 
of infant and child survival [13], these comorbidities still impact on quality of life for 
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families and children with Down syndrome. However, despite the magnitude of this 
problem limited literature has described the overall health status of children with Down 
syndrome. Therefore the objective of this narrative literature review is to describe the 
medical conditions commonly experienced by children with Down syndrome and to 
consider the clinical implications of this knowledge. 
Methods 
Databases Medline, CINHAL and PsychiNFO were electronically searched to identify 
relevant articles. The data bases were searched from 1990 to 2009 so as to only include 
the most recent literature in this review. The databases were also restricted to include 
only peer reviewed published articles, English articles and those which included children 
younger than 18 years. The main search terms were: Down syndrome, medical 
conditions, cardiac, gastrointestinal, respiratory, ophthalmic, ear, hearing, thyroid, 
diabetes, musculoskeletal, cancer and leukaemia. These terms were truncated and 
exploded to include all relevant disorders and terminology under these headings. Search 
terms were also adjusted to match the specific database being searched. Articles were 
included if they focused on children aged 18 years or younger with a diagnosis of Down 
syndrome, and one or more medical co-morbidities. 
The intention of this review was to provide an overview of the most current and relevant 
literature and therefore focused on more recent literature discerning important results. 
Articles were excluded at the title or abstract level if they did not meet the inclusion 
criteria. Conference proceedings were not searched. Formal quality appraisal was not 
performed however within epidemiological studies this is not commonly undertaken [19]. 
Furthermore, no meta-analysis was performed in this literature review due to significant 
differences between cohorts (population, school or hospital based cohorts) and the 
different methods of collecting prevalence estimates. 
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Results 
A review of the literature supports the conclusion that children born with Down 
syndrome commonly experience a variety of additional birth defects and other health 
related problems. Medical conditions commonly associated with Down syndrome 
include; cardiac and gastrointestinal disorders, musculoskeletal problems, respiratory 
problems, eye and visual defects, ear and hearing defects, and frequent episodic illnesses 
and infections. In addition, research has also highlighted the increased risk that children 
with Down syndrome have of developing leukaemia and thyroid conditions. 
Congenital heart defects 
Cardiac defects are reported to be the most common occurring birth defect associated 
with Down syndrome, with prevalence estimates ranging between 40-50% [16, 20]. The 
most frequently occurring congenital heart defects include atrioventricular septal defect 
(AVSD), atrial septal defect (ASD), ventricular septal defect (VSD), tetralogy of Fallot 
[21], and patent ductus arteriosus (PDA) [22]. Congenital cardiac defects have been a 
major cause of mortality for children with Down syndrome [2, 17]. Even with advances 
in corrective surgery for cardiac malformations, which have resulted in significant 
improvements in survival and quality of life among children with Down syndrome, 
cardiac disease still remains a major predictor of mortality [15]. 
Gastrointestinal disorders 
Children with Down syndrome experience a higher prevalence of gastrointestinal 
disorders than their peers [23, 24] with congenital gastrointestinal defects occurring in 
approximately 6. 7% of infants with Down syndrome [25]. Commonly experienced 
gastrointestinal disorders include duodenal atresia, congenital malformations of the colon 
and rectum, Hirschsprung disease [23], gastro-oesophageal reflux [26] and coeliac 
disease [27, 28]. In addition, constipation, although not a serious condition, is relatively 
common among these children and often involves prolonged management, placing 
increased demands on family and carers [29]. 
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Although there was considerable literature pertaining to prevalence and screening for 
coeliac disease, [30-33], research on serious congenital gastrointestinal defects is less 
comprehensive. This could be attributed to increases in corrective surgery undertaken in 
infancy resulting in fewer cases of gastrointestinal disorders present in childhood. 
Hirschsprung's disease however is an exception with a higher representation within the 
literature. The long term outcomes of Hirschsprung' s disease have been researched and 
indicate that incontinence or soiling is frequent among children with Down syndrome and 
Hirschsprung's disease [34], although studies have also demonstrated no statistical 
significance between outcomes in children with or without Down syndrome and 
Hirschsprung's disease [35, 36]. Results in all studies should however be viewed with 
caution due to the small sample sizes. Further population based research is needed 
regarding congenital gastrointestinal disorders by children with Down syndrome and the 
outcomes and ongoing implications of the disorders for the children, families, and the 
health care system. 
Respiratory problems 
Respiratory conditions including pneumonia, bronchitis and obstructive sleep apnoea are 
considered a major cause of morbidity for children with Down syndrome. Respiratory 
infections are the leading cause for hospital admissions among children with Down 
syndrome beyond the neonatal period, especially for those with congenital heart disease 
[37] and are shown to be a major cause of death [3]. However, due to the varied means of 
data attainment, discrepancies in the literature exist as to whether respiratory or cardiac 
defects contribute most to mortality in children with Down syndrome. 
Obstructive sleep apnoea, which involves complete or partial upper airway obstruction 
during sleep, is reported to occur in approximately 60% of children with Down syndrome 
[38, 39]. The higher prevalence of this condition can be attributed to common 
physiological and anatomical characteristics observed in children with Down syndrome 
including midface hypoplasia, large adenoids or tonsils, narrow nasoorophaynx and 
eustachian tubes, systemic hypotonia [27] and inner ear dysplasia [40]. It is reported that 
parents substantially underestimate the prevalence and severity of obstructive sleep 
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apnoea assuming that irregular breathing during sleep is normal for children with Down 
syndrome [38]. As obstructive sleep apnoea may be associated with lower IQ 
performance [ 41] and behaviour probl~:ns [ 42], parents need to be informed of the 
prevalence of sleep apnoea and its associated implications. 
Ophthalmic defects 
Ophthalmological problems are over represented in the Down syndrome population and 
if not corrected can result in substantial secondary disability [26]. Common 
ophthalmological disorders include refractive errors, strabismus, nystagmus and 
congenital cataracts [43, 44]. Hyperopia and myopia occur in approximately 43% of 
children with Down syndrome [44] and contribute to their fivefold increased likelihood 
of wearing glasses compared to. their peers [29]. In addition, as children with Down 
syndrome frequently present with poor accommodation [ 45], bifocal spectacles should be 
considered for those who under-accommodate [46]. Strabismus, occurring in 
approximately 42% of children with Down syndrome, also contributes to vision 
impairment [47], and is positively associated with learning difficulties [48]. As sensory 
defects contribute substantially to disability, vigilant monitoring is required for children 
with Down syndrome to optimise opportunities for learning and development, and to 
increase quality of life. 
Ear and hearing defects 
Children with Down syndrome have a high incidence of hearing impairment [28, 49]. 
Hearing loss is reported to be prevalent in over 50% of children with Down syndrome 
[26] and is defined as conductive, sensorineural or mixed [28]. While conductive hearing 
loss arises frequently in children with Down syndrome due to episodes of otitis media or 
middle ear dysfunction, sensorineural hearing impairments become increasingly 
prevalent with age [50]. It is recommended that children with Down syndrome undergo 
regular audiological screening for early identification of hearing impairments to minimise 
or correct hearing loss and reduce secondary speech problems [51]. 
Anatomical malformations, systemic hypotonia and an increased susceptibility to 
infections result in a high incidence of otitis media among children with Down syndrome 
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[52] and can lead to glue ear and transient conductive hearing loss. Although grommet 
insertion is disproportionately higher among children with Down syndrome compared to 
the general population [53], a systematic review concluded that this procedure is only 
minimally effective in reversing this loss [54]. Conversely, results qf a longitudinal study 
have suggested that aggressive evaluation and treatment of chronic otitis media 
significantly improves hearing levels in children with Down syndrome [55]. Clearly more 
research is needed to guide clinical interventions in this area. 
Musculoskeletal problems 
Approximately 20% of children with Down syndrome experience musculoskeletal 
disorders [56] due to a predisposition to hypotonia, lax ligaments and skeletal dysplasias 
[26]. Commonly occurring musculoskeletal conditions include: patellar instability, 
metatarsus primus, pes planus (flat foot), scoliosis and atlantoaxial instability [57]. Minor 
podiatric anomalies including pes planus, foot pronation and metatarsus primus, are often 
neglected due to a greater focus on the more severe pathologies associated with Down 
syndrome [58] . There is therefore a need to ensure early identification of minor 
musculoskeletal impairments is provided to prevent subsequent biomechanical and 
postural problems. 
Atlantoaxial instability, reported to occur in approximately 10% to 20% of people with 
Down syndrome [59], has been considered to be particularly dangerous due to the 
potential risk of compression and damage to the spinal cord. Atlantoaxial instability is 
primarily attributed to laxity of the transverse ligament which results in instability of the 
spine at Cl-C2 [59], or as a result of hypoplasia or malformations of the odontoid [57]. 
Previously, fear of the potentially catastrophic consequences of atlantoaxial instability led 
to recommendations for routine screening and the restriction of certain sporting activities 
[26]. These recommendations have now been revised such that routine screening is 
mainly indicated for children with Down syndrome who are symptomatic or who 
participate in contact sports [60]. 
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Endocrine 
Endocrine anomalies, especiallythyroid dysfunction [61] and diabetes [62], are reported 
to be more common among people with Down syndrome than the general population. 
Estimates of thyroid dysfunction among people with Down syndrome have varied from 
approximately 8.5% [61] to 38% [63). These estimates vary in relation to population 
characteristics (age, size, race), diagnostic criteria and variations in operational 
definitions used in studies. Hypothyroidism can be congenital or acquired and has a 
greater prevalence than hyperthyroidism with approximately 10% of school aged children 
with Down syndrome having this condition [26). As the prevalence of hypothyroidism 
increases with age, and is similar in its presentation to Down syndrome itself, early 
annual biochemical screening has been previously recommended to identify thyroid 
disease [ 60]. In America, rates of medically treated thyroid disease in people with Down 
syndrome increased by 73% after the release of the American Academy of Pediatrics 
Health Supervision Guidelines [64]. Although these rates are based on a study with 
limited generalisability due to its sample selection, the benefits of increased physician 
awareness and subsequent rates of screening can be seen. However, there is disagreement 
)} 
over the frequency of screening for thyroid dysfunction with some authors concluding 
that annual screening in not justified within the first two decades of life [ 61]. 
Down syndrome is also associated with diabetes and is reported to have a prevalence rate 
between 1.4 and 10.6% for Type 1 [65]. The increased prevalence for Type 1 diabetes 
may be genetically linked to the mutation of chromosome 21 which may be associated 
with the early onset and high frequency of autoimmune diseases [66]. As diabetes is 
relatively common among people with Down syndrome in comparison to the general 
population, further research should examine the substantial secondary health concerns 
experienced by children with diabetes, and the increased carer responsibility regarding 
monitoring of dietary requirements and medication management. 
Leukaemia 
Although the overall risk of cancer for people with Down syndrome is equal to the 
general population, the risk of developing leukaemia is significantly higher [67, 68). 
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Children with Down syndrome have a nineteen fold increased risk of developing 
leukaemia than their normally developing peers [69, 70], with the m~ority of cases being 
diagnosed before the age of five [68]. This increased risk is apparent in data from the 
Western Australian Cancer Registry with 53% of all cancers recorded in people with 
Down syndrome resulting from childhood leukaemia [3]. Although survival outcomes 
following treatment for leukaemia for children with Down syndrome are similar to the 
general population, treatment is often poorly tolerated [28]. This may be associated with 
the high levels of comorbidity experienced by children with Down syndrome which 
complicate treatment and management regimes. 
Interestingly, people with Down syndrome in all age groups have a decreased risk of 
solid tumours [67, 68, 71]. Possible reasons for this decrease may be related to reduced 
exposure to environmental carcinogens or directly related to the tumour -suppressor 
genes found on chromosome 21 [72]. It has been hypothesised that as people with Down 
syndrome have three copies of the tumour-suppressor genes due to their extra 
chromosome 21, their cells are less likely to lose all three functional copies of the 
tumour-suppressor genes [72] which may therefore provide greater protection against 
tumours. 
General infections/viruses 
Structural abnormalities and an immature immune system result in children with Down 
syndrome being predisposed to recurrent infections and episodic illnesses. Commonly 
occurring conditions include upper-respiratory infections [28, 73] and otitis media [28, 
55]. Poorer immune functioning, leading to greater susceptibility to infection, is further 
aggravated by frequent attendance at health care appointments, and comorbidity of 
cardiac and pulmonary diseases [73]. 
A recent US population-based study demonstrated that children with Down syndrome 
had a higher prevalence of ear infections, recent colds/flu, stomach illnesses and 
diarrhoea than did children without Down syndrome [24]. A major contributor to this 
increased susceptibility to illnesses is the array of immune dysfunctions affecting people 
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with Down syndrome [74], including severely diminished expansion of T and B 
lymphocytes [70]. Although the majority of the episodic illnesses common in children 
with Down syndrome are not life threatening, their prevalent and recurrent nature may 
add significantly to health care utilisation, increase the financial and emotional impact on 
carers, and contribute to an overall decreased quality of life. 
Discussion 
As outlined, Down syndrome is associated with many co-morbid conditions, health 
problems and an increased risk of mortality compared to the general population. 
Improvements in the medical management of co-morbidities and surgical advances have 
reduced morbidity among children with Down syndrome, however congenital cardiac 
defects, along with respiratory problems are still considered a major cause of mortality 
[3]. Children with Down syndrome are predisposed to an array of health conditions and 
impairments, transcending the sensory, endocrine, musculoskeletal and haematological 
systems. While the estimated prevalences for these conditions vary between studies, this 
is likely the result of diverse sample characteristics, data collection methods, coding 
terminologies and study methodologies (population-based versus clinical or hospital 
based). Overall, it is evident that high levels of co-morbidity significantly impact on the 
quality oflife for children with Down syndrome and their families. 
Parents of children with Down syndrome may experience an emotional and financial 
impact from the medical co-morbidities experienced by their child. Parents have reported 
that their child's increased needs had diminished their finances to the extent that 
recreational activities and material items were often unaffordable [75]. Having a child 
with Down syndrome has also been associated with limited parental time for other 
children, reduced family socialisation [75] and poor maternal health [76]. Parents 
therefore need a clear understanding of the medical co-morbidities associated with Down 
syndrome to assist in making informed decisions regarding possible terminations of 
pregnancy or in making future plans for their child and family. 
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Despite the widespread acknowledgement of the co-morbidities experienced by children 
with Down syndrome and their health effect, limited literature is available on medical 
utilisation and health expenditures. A Western Australian study [29] presented an 
overview of service utilisation for children with Down syndrome. However, as the role of 
the Disability Services Commission, which coordinated medical services for people with 
an intellectual disability, has since changed, these data may no longer reflect the actual 
service use of children with Down syndrome in Western Australia. For children under 
five with Down syndrome, medical costs were 12 to 13 times higher than in the general 
population [77]. Also, children under five with an intellectual disability were more likely 
to be admitted to hospital and for longer periods of time than their peers [78]. However, 
limited research has examined health service utilisation for children over five with Down 
syndrome or how the need for medical care changes with age. This knowledge would 
result in a better understanding of the service needs for this population and assist in 
provision and resource allocation of disability and medical services. 
This literature review has implications for screening and subsequent management of co-
morbidities. Many of the co-morbidities experienced by children with Down syndrome, if 
left untreated, contribute to substantial secondary disability, resulting in unnecessary 
hardship and further disadvantage. Sensory defects are a primary example. As vision and 
hearing contribute to learning, language development and socialisation [48, 79, 80], the 
lack of regular screening and subsequent management of impairments not only affects the 
sensory systems involved but a child's chances of academic success and socialisation. 
Furthermore, as some children with Down syndrome are reported to have a as few as one 
reciprocal friend [81, 82], and experience limited peer interactions outside school [81], 
the importance of minimising disability and limiting secondary disability is highlighted. 
Guidelines for the screening of medical conditions associated with Down syndrome have 
been published [27, 51, 60]. However, to what extent these are actually being 
implemented within schools and the health care system remains unknown. Further 
research is needed to provide an understanding of the current screening policies and 
guidelines being implemented and their effectiveness in identifying all the health 
conditions experienced by children with Down syndrome. 
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Finally, this literature review has important implications for health care professionals and 
education providers. A clear understanding of the co-morbidities experienced by children 
with Down syndrome provides a base for health care providers to plan and deliver safe 
and effective intervention programs suitable for each child's physical capacities and 
limitations. Knowledge of medical conditions is also valuable to health care professionals 
who are in a position to provide prospective parents with current information to facilitate 
informed decision making and future plans. In addition, as teachers play a valuable role 
in children's development, an understanding of the medical conditions and their 
functional impact on children with Down syndrome may facilitate the implementation of 
classroom strategies which minimise disability and foster academic achievement and 
socialisation with peers. 
This literature review has synthesised the most current and relevant literature relating to 
the medical conditions experienced by children with Down syndrome, however its 
limitations must be acknowledged. As this was not a systematic review the 
methodological quality of the research was not formally evaluated. Instead, this narrative 
literature review was undertaken to summarise findings and provide an overview of the 
common medical conditions experienced by children with Down syndrome. Furthermore, 
a meta-analysis was not performed due to the differences between cohorts (population, 
school or hospital based cohorts) and the varied methods of collecting prevalence 
estimates. 
Conclusion 
This review of the literature supports the conclusion that many children with Down 
syndrome experience additional birth defects and health related problems which impact 
on their quality of life. Medical conditions commonly associated with Down syndrome 
include; cardiac and gastrointestinal disorders, musculoskeletal disorders, respiratory 
problems, eye and visual defects, ear and hearing impairments, and frequent episodic 
illnesses and infections. In addition, children with Down syndrome have an increased risk 
of developing leukaemia and thyroid conditions. Although considerable research has 
documented these conditions, there is limited research examining the impact of levels of 
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co-morbidity on everyday functioning. Understanding the impact of high levels of co-
morbidity would lead to the development of more effective interventions for teachers and 
health care professionals, and also assist in the provision and resource allocation of 
disability services. 
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Changes over time in medical conditions and service use by children 
with Down syndrome 
Background: Children with Down syndrome commonly experience a variety of medical 
conditions and health care problems. Although vast improvements in the medical 
management of these conditions has occurred, changes in the overall health status of 
children with Down syndrome over time, is yet to be explored. Furthermore, research is 
limited which examines service utilisation for children with Down syndrome or the 
impact of socio-demographic factors on access to services. 
Aim: To compare the prevalences of parent reported medical conditions, and use of 
services, by school aged children with Down syndrome in Western Australia between 
1997 and 2004. In addition this study aims to describe the impact of socio-demographic 
factors on medical service utilisation in 2004. 
Methods: This study involved the comparison of two cross sectional surveys completed 
by parents of children with Down syndrome in 1997 and 2004. The surveys collected 
information of family demographics, medical conditions, health issues and service 
utilisation. Frequency distributions were used to describe medical conditions in 2004 and 
formal tests of association were based on chi-square tests. Regression analyses were used 
to compare medical conditions and service use between the 1997 and 2004 cohorts. 
Results: Children with Down syndrome in 2004 had significantly greater odds of having 
a bowel condition than children in 1997 (OR 1.68, 95% CI 1.16 - 2.45). In 2004 children 
had approximately 50% less likelihood of having a current problem due to their cardiac 
condition (OR 0.52, 95% CI 0.28-1.00). An overall reduction in the incidence rates of 
episodic illnesses and infections was seen in 2004. The use of GP services (IRR=0.91, 
95% CI 0.83, -1.00) and combined medical specialist visits (IRR=0.92, 95% CI 0.84-
1.01) were reduced in 2004. Overnight hospital admissions (IRR 0.60, 95% CI 0.37 -
0.96) and length of stay (IRR 0.33 95% CI 0.24- 0.44) were also reduced in 2004. 
Conclusion: The health status of children with Down syndrome has varied over time. 
Most importantly, children in 2004 experienced a significant reduction in current cardiac 
problems and episodic illnesses that may contribute to improvements in overall health 
and impact quality of life. In addition, children with Down syndrome are using less 
medical services in 2004. These findings have implications for parents, health 
professionals and in the provision and resource allocation of disability services in 
Western Australia. 
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Changes over time in medical conditions and service use by children 
with Down syndrome 
Introduction 
Down syndrome is a chromosomal birth disorder and the single most common cause of 
intellectual disability [1 ], affecting 1 per 1000 births. It is well documented that Down 
syndrome is strongly correlated with maternal age [2]. Major demographic shifts in 
westernised societies have resulted in increasing maternal age due to the changing roles 
of women leading to the postponement of pregnancy. As a result, the number of overall 
Down syndrome pregnancies has increased [2]. However, with the greater utilisation and 
accessibility of antenatal screening programs [4], and increases in terminations of 
pregnancies [5], the prevalence of Down syndrome births has remained relatively stable. 
Children with Down syndrome experience an array of medical conditions and health care 
problems which have been widely documented. There is a predisposition for children 
with Down syndrome to develop medical co-morbidities [6] which may present ongoing 
health issues and contribute to an increased risk of developing recurrent episodic illness 
and infections. However, improvements in the medical management of these conditions 
has lead to increased rates of infant and child survival and decreased morbidity [7]. These 
medical improvements include, surgical advances and management of congenital heart 
defects [8], improved accessibility to antibiotics and vaccinations, and changes in 
community and health professionals' attitudes towards the treatment methods for people 
with Down syndrome [9]. With these improvements in health management, it is expected 
that further improvements in the health of children with Down syndrome will be seen 
over time. 
Although data are limited, there is a growing body of research which suggests that 
children with Down syndrome have higher rates of health utilisation than their peers [10-
12]. However, to our knowledge, no literature has examined changes in service utilisation 
over time, especially within the Down syndrome population. Furthermore, since 2002, 
Western Australia has seen changes in the provision of disability medical specialist 
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services with these services no longer being provided by the Disability Services 
Commission (DSC). As a result the service utilisation of children with Down syndrome, 
and how these have changed over time, is currently unknown. Furthermore, the impact of 
socio-demographic factors on accessibility of medical services for children with Down 
syndrome is also unexplored. As families of children with an intellectual disability are 
shown to be more frequently economically disadvantaged [13], it is reasonable to assume 
that inequalities exist in access and utilisation of specialist medical services which are not 
fully government subsidised. An understanding of the socio-demographic disparities 
which exist for families of children with Down syndrome is important for effective policy 
development and equality in resource allocation. 
Although the benefits of improved medical management have been described in terms of 
survival [8,14], limited literature has examined the reduction of co-morbidities, or the 
general health and frequency of illnesses in children with Down syndrome over time. 
With the improvements of medical care, and more effective treatments early in life, it is 
expected in this study that children with Down syndrome would experience less episodic 
illnesses and ongoing problems associated with their medical conditions over time. 
Furthermore, we predicted that with these reductions in illnesses and ongoing problems 
due to medical conditions, coupled with the restructuring of the specialist services out 
into the community, a decline in service utilisation may be evident. Finally, we aim to 
describe the impact of socio-demographic factors on medical service utilisation and 
examine whether they impacted on specialist medical services which are not fully 
government subsidised. 
Methodology 
Methods 
This study involved the comparison of two cross sectional surveys conducted in 1997 and 
2004 using a Western Australian population data source of children with Down 
syndrome. Figure 1 illustrates the study process. In 1997 cases were principally 
ascertained directly through the Disability Services Commission (DSC), a government 
body coordinating medical and therapy services in Western Australia for people with an 
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intellectual disability. Families with a child with Down syndrome born between 1980 and 
1991, living in Western Australia were identified and mailed a questionnaire. The total 
response fraction obtained was 79.5% (n = 210/264). 
In 2004 a second survey was conducted with cases identified through the Intellectual 
Disability Exploring Answers (IDEA) database, a population data source which uses 
multiple sources of ascertainment including the Disability Services Commission and the 
Department of Education and Training [15]. Five hundred families, with a child with 
Down syndrome were aged 25 years and younger and registered with the Disability 
Service Commission, were invited to participate in the study. In 2004, the total response 
fraction was 73% (n = 363/500). The present analysis restricted data to subjects who were 
school aged in 2004 (n=208) to ensure a comparable age sample to the 1997 cohort. 
Instruments 
The 1997 and 2004 ·questionnaires sent to families of children with Down syndrome 
obtained similar information on family demographic characteristics, medical conditions 
and health related conditions experienced by their child. Questions relating to medical 
conditions asked if the child with Down syndrome had ever had a certain medical 
condition, and if so, was the condition considered a current problem or requiring ongoing 
medical treatment. In addition, the questionnaire gathered information on health service 
utilisation including type and frequency of health care professional visits over the 
previous 12 months. Both questionnaires were pilot tested to ensure their capacity to 
elicit relevant and important information. 
Data coding and management 
In coding the data children were categorised into three age groups (5-9 years; 10-13 
years; 14-17 years). Socio-demographic predictors used in data analysis for the 2004 
cohort included parental education, father's occupational skill level, maternal work 
status, family income and place of residence (See Table I). Participants' postcodes were 
used to categorise place of residence. Father's occupational skill level was based on the 
Australian and New Zealand Standard Classification of Occupations [16], however 
categories were recoded so that the lowest skill level would become the baseline. Data 
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was entered into FileMaker Pro version 8.0, and variables consistently categorised across 
the two cohorts. Data were then exported into STAT A version 10 and the 1997 and 2004 
data were linked for statistical analysis by matching on DSC record numbers. 
Ethics approval for the 1996 study was granted by the Ethics Committee at Princess 
Margaret Hospital for Children, and by the Disability Services Commission. Ethical 
approval for the 2004 study was obtained through the Ethics Committee of the Women's 
and Children's Health Services in Western Australia. Approval to link the two data sets 
was obtained directly from the Disability Services Commission. Ethical approval for the 
current study was granted by the Edith Cowan Human Research Ethics Committee. 
Data analysis 
The prevalences of medical conditions in 2004 were described as frequency distributions. 
Formal tests of association between medical conditions and child characteristic factors of 
age or gender, were based on chi-square tests. P-values below 0.05 were considered 
statistically significant, however the clinical meaning of differences in variables was also 
considered. The 2004 medical services, hospital admissions and episodic illnesses data 
were annualised in order to provide an estimate comparable to the 1997 data. Logistic 
regression was used to compare the prevalence of medical conditions between 1997 and 
2004, and Poisson regression to compare rates of episodic illnesses and medical service 
use. Two outliers where the respondents had clearly misinterpreted the question about 
the use of medical services were excluded. To account for overlap of children within the 
1997 and 2004 cohorts, regression analyses were conducted within a generalised 
estimating equation framework [1]. Analysis of the impact of socio-demographic factors 
on service use in 2004 involved multivariate regression models. Hospitalisation rates for 
the general population for school aged 5-17 years in 1997 and 2004 were accessed [18], 
and incidence rate ratios calculated in order to make comparisons between the general 
population and children with Down syndrome. 
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Results 
Sample characteristics 
The sample characteristics of the 1997 cohort have previously been described in detail 
[19]. Table I outlines the socio-demographic characteristics of families in 2004. The 
mean age ofthe 2004 study subjects was 11.7 years (range 5.02 -17.98) and there were 
90 females and 118 males. All children whose parents responded 202/202 (100%) lived 
in their family home and 135/149 (90.6%) lived with both parents. Mothers provided the 
majority of day-to-day care needs in 200/208 (96.2%) cases. 
Medical conditions 
Medical conditions in the 2004 cohort 
Specific medical conditions in school aged children with Down syndrome in the 1997 
cohort have been previously described [19]. The medical conditions in the 2004 cohort 
are shown in Table II. Cardiac conditions were present in 95 (55.7%) children, with the 
most common cardiac conditions being ventricular septal defects (N=33, 16%) and atrial 
septal defects 25 (12% ). Congenital bowel conditions were reported in 66 (31. 7%) 
children, with duodenal atresia occurring in 9 ( 4.3%) cases, while constipation was 
present in 20% (N=41) of children with Down syndrome. Over half of the children were 
reported to have had an ear condition 123 (59.1%). Glue ear occurred most frequently 
(86, 41.3%) while hearing loss was reported in 36 (17.3%) children. Over two thirds of 
children presented with visual defects (140, 67.3%), the most frequent ofthese were short 
sightedness (52, 25%) and strabismus (45, 21.6%), while parents of 45 (21.6%) children 
reported their child was long sighted. Twenty-six (12.5%) parents reported their child to 
have had a thyroid disorder, with hypothyroidism occurring in 22 (22.6%) of children and 
hyperthyroidism reported in three (1.4%) children. No statistically significant differences 
were apparent across age groups or gender for all these medical conditions. 
Seventy-four (35.6%) children were reported to have ever had a musculoskeletal 
condition. Flat feet occurred most frequently (N= 47, 22.6%) and were more common 
among girls (X2 =6.6, P= 0.01). Twenty-eight (59.6%) of these children wore orthotics 
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and use was again higher among females (X2 =5.65, P=0.02). Fifty eight (27.9%) children 
had had X-rays of the cervical spine and in 4.3% (N=9) a diagnosis of atlantoaxial 
instability had been made. Forty-eight (65%) parents reported that their child currently 
experienced a problem associated with their musculoskeletal condition and this was most 
commonly flatfeet (29/48, 60.4%). 
Two thirds (126/208, 60%) of children had ever had a respiratory condition. Nearly 20% 
of children were reported to have sleep apnoea and 42 (20.2%) had asthma. No 
association was found between respiratory conditions and gender, however sleep apnoea 
was more.prevalent in the 10-19 year old age group (x2= 7.89, P=0.02). Only 15% of 
parents reported that their child had current or continued respiratory problems and no 
statistically significant difference was apparent across age groups (x2 = 3.92, P=0.14). 
Medical conditions in 2004 compared with 1997. 
Table III outlines the likelihood of medical conditions and episodic illnesses in children 
with Down syndrome in 2004 compared with 1997, including if they have ever had the 
medical condition, and if they experience current problems associated with the condition. 
School-aged children with Down syndrome in 2004 had greater odds (OR 1.68; 95% CI 
1.16 - 2.45) of having any bowel condition than children in 1997 even after adjusting for 
age (OR 1.69; 95% CI 1.13 - 2.52), and gender (OR 1.65; 95% CI 1.13 - 2.37). 
Specifically, children in 2004 had higher odds of having a congenital bowel condition, 
mainly duodenal atresia (OR 1.17; 95% CI 0.60- 2.28) as well as constipation (OR 1.20; 
95% CI 0.77- 1.86). In 2004, children had a slightly higher likelihood of ever having a 
cardiac (OR 1.11; 95% CI 0.90 - 1.39), ear (OR 1.13; OR 0.18 - 1.56) or thyroid 
condition (OR 1.08; 95% CI 0.69 =- 1.70), and hearing loss had a 13% increased 
likelihood (OR 1.13; 95% CI 0.68- 1.90). In 2004 there was a reduced prevalence of 
overall eye conditions (OR 0.79; 95% CI 0.55 - 1.15), however long sightedness was 
increased (OR 1.54; 95% CI 1.03 - 2.31) as was the likelihood of wearing glasses (OR 
1.18; 95% CI 0.83- 1.66). 
Children in 2004 had approximately 50% less likelihood of having a current problem due 
to their cardiac condition (OR 0.52; 95% CI 0.28-1.00) which was further reduced when 
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adjusting for age and gender (OR 0.32; 95% CI 0.15 - 0.68). In 2004, there was an 
increased likelihood of bowel (OR 1.29; 95% CI 0.77 - 2.18), ear (OR 1.06; 95% CI 
0. 74- 1.53) and thyroid (OR 1.54; 95% CI 0.89 - 2.66) conditions causing a current 
problem or requiring ongoing treatment, while eye conditions showed a reduction (OR 
0.84; 95% CI 0.60 -1.18) 
An overall reduction in the incidence rates of episodic illnesses and infections among 
children with Down syndrome was found in 2004 compared to 1997. The greatest 
reductions were seen for episodes of tonsillitis (IRR 0.56; 95% CI 0.38-0.83) and ear 
infections (IRR 0.77; 95% CI 0.62- 0.95). 
Medical service use 
Table IV illustrates the rate of service use in 2004 compared to 1997. The use of a 
general practitioner (GP) (IRR 0.91; 95% CI 0.83 -1.00) and the combined medical 
specialist visits (IRR 0.92; 95% CI 0.84- 1.01) showed a slight rate reduction in 2004. 
There was also a reduction in disability specialist services (IRR 0.25; 95% CI 0.15- 0.41) 
and audiologist use (IRR 0.80; 95% CI 0.61 - 1.04), but an increase for ear, nose and 
throat (ENT) (IRR 1.12; 95% CI 0.89- 6.88), podiatry (IRR 0.67; 95% CI 0.50- 0.91) 
and 'other' specialists (IRR 1.29; 95% CI 0.97- 1.72). Cardiologists were unable to be 
compared over the two years due small numbers in cardiologist attendance. 
Overnight hospital admissions (IRR 0.60, 95% CI 0.24- 0.44) and the total nights spent 
in hospital (IRR 0.33 95% CI 0.24- 0.44) both showed marked decreased incidence rates 
in 2004 compared with 1997. This paralleled, but was reduced further than the general 
population of Western Australian school-age children for these two years (OR 0.88, 95% 
CI 0.86 - 0.90). With respiratory conditions (IRR 0.28, 95% CI 0.09 - 0.90), there was 
the greatest reduction in hospital admissions in 2004 with the average nights in hospital 
decreasing from approximately five in 1997 to 1.6 nights in 2004. However there was an 
increased rate of day hospital admissions (IRR 1.20, 95% CI 0.81 - 1. 76) in 2004 and in 
both years these were commonly associated with dental procedures. This increase 
paralleled the increase seen in the general population (OR 1.33 95% CI 1.29 - 1.36). 
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The frequency of surgical interventions was reported in 1997 and 2004. The odds of 
having cardiac and ENT surgery were comparable across years (OR 1.08; 95% CI 0.88-
1.32) and (OR 1.01; 95% CI 0.74 - 1.38), respectively. However, in 2004 there was a 
reduced likelihood of children having had eye surgery (OR 0.92; 95% CI 0.58 - 1.46), 
and a 70% increase in the likelihood ofbowel surgery (OR 1.71; 95% CI 0.83- 3.52). 
Impact of socio-demographic factors on service use in 2004 
Table V outlines the effects of socio-demographic factors on service use for children with 
Down syndrome. After adjusting for fathers' occupational skill level, family income, 
maternal work status and place of residence, the rates of GP service use were three times 
higher for children whose fathers were well educated (IRR 3.33; 95% CI 2.52- 4.41). All 
fathers' skill levels above the baseline showed reductions in service use and children had 
a comparable rate of GP service use for rural and metropolitan areas (IRR 1.00; 95% CI 
0.81- 1.24). 
After adjusting for the other socio-demographic factors, higher paternal education was 
associated with increased specialist service use (IRR 1.63; 95% CI 1.30- 2.05). Children, 
whose family's annual income ranged from $20 000 - $31 999, or $32 000- $51 999, 
demonstrated the highest rates of service use, and had the strongest effect size within 
income. Father's skill level had an opposite effect, with the lowest skill level (the 
baseline) showing the highest rates of specialist service use. Working mothers were 
associated with reduced use of services (IRR 0.85; 95% CI 0.72 - 0.99) and little 
difference was found between children living in rural or metropolitan areas (IRR 1.05; 
. 95% CI 0.88- 1.27). 
Within the model for overnight hospital admissions, none of the socio-demographic 
indicators had statistically significant effects, except for father's occupational skill level 
ofthree (IRR; 0.15, 95% CI 0.028- 0.83) and four (IRR; 0.28; 95% CI 0.08- 0.99) which 
both demonstrated a reduction in overnight hospital admissions. Hospital day admissions 
however, demonstrated a strong association between higher maternal education and 
increased service use (IRR; 5.15, 95% CI 1.71 - 15.55). Significantly reduced hospital 
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day admissions were seen for fathers who had an occupational skill level of one (IRR 
0.23; 95% CI 0.08 - 0.63), three (IRR 0.30; 95% CI 0.12- 0.81) and four (IRR 0.28; 
95% CI 0.12- 0.66) compared with the baseline which was the lowest skill level. Family 
income showed no statistically significant associated with hospital day admissions. 
Discussion 
This study aimed to compare the prevalences of medical conditions and episodic illness 
in 1997 and 2004 to see if an improvement in the health of children with Down syndrome 
has occurred over time. In addition, this study compared the use of medical services 
between these years in order to assess if the improved health of children with Down 
syndrome, or the disbandment of specialist services at the Disability Services 
Commission, has led to decreases in service use. Furthermore, the impact of socio-
demographic factors on service use was described. The results of this study found a 
significant reduction in ongoing cardiac conditions, while bowel and thyroid conditions 
proved to be associated with increased ongoing problems in the later cohort. Eye 
conditions showed a 20% reduction, while hearing loss had increased by 13% in 2004. Of 
importance, was that episodic illnesses reported to have an overall reduction in 2004 
indicating the improved health and reduction in illnesses not genetically encoded in 
children with Down syndrome. Service use paralleled these results, showing a reduction 
in both GP and specialist appointments, while overnight hospital admissions were also 
significantly reduced. Higher paternal education appeared to have the strongest 
relationship to increased service use in the majority of analyses, and socio-demographic 
factors had the strongest impact on specialist and GP service use. 
The most important finding in this study was the 50% reduction in parent reported current 
cardiac problems in 2004 compared with 1997. It is therefore likely that this later cohort 
may have benefited considerably from the recent improvements in early surgery and as a 
result have less ongoing comorbidity associated with their heart lesions compared with 
the earlier cohort. Several studies highlight the changing survival profile of children with 
Down syndrome [8,14,19] which attribute increased survival mainly to advances in 
cardiac surgery and the improved medical management of these conditions. As a result, 
children with Down syndrome are able to experience not only improved survival, but a 
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significant decline in the ongoing cardiac comorbidities which pose a health risk for 
children with Down syndrome and affect quality of life. 
In 2004, children were reported to have an overall reduction in the number of episodic 
illnesses and infections. These results would be in line with the improved cardiac status 
we observed in 2004 as ongoing cardiac conditions often contribute to secondary 
illnesses [20]. The improved health of children with Down syndrome can also be 
attributed to greater access to, and effectiveness of, antibiotic treatments and vaccinations 
within the health care system [9]. In the later cohort, ear infections especially were found 
to have the highest rate of reduction. Given the similar rate ofENT surgery in both years 
and the increased use of ENT specialists in 2004, the results indicate a trend towards 
increased preventative health care which focuses on medical treatment other than surgical 
intervention. The reduction in episodic illnesses was also reflected in the use of GP 
services which saw a significant reduction in 2004. Our study is unique as it would 
appear to be the first to have used population data to address rates of illnesses and 
infections and service use, in children with Down syndrome over time. However, given 
the reductions seen in episodic illnesses and infections, our study would support the 
thesis that the health of children with Down syndrome has improved in recent years. 
Hearing impairments in children with Down syndrome are well documented [21,22]. In 
2004, a 13% increase in the number of Western Australian school-aged children with 
hearing loss was found compared with 1997. As hearing is vital to language development 
[23], and therefore contributes to learning and socialisation, regular screening and 
subsequent management of impairments is vital in facilitating chances of academic 
success and socialisation for children with Down syndrome. With the statistically 
significant reduction in the use of audiologist services, and the increase of hearing loss 
seen in the later cohort, our findings show some support for children with Down 
syndrome to undergo regular screening for early identification of hearing impairments 
[24] in order to minimise disability and limit secondary disability. 
In 2004 parents reported higher rates of ongoing problems or the requirement of 
continued treatment for thyroid and bowel conditions. For thyroid conditions, this might 
be expected as once hypothyroidism is diagnosed, treatment is ongoing [25]. 
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Furthermore, greater awareness and the possible recognition and identification of thyroid 
disease [26] in later years may also account for some of the increase in thyroid 
conditions requiring treatment. In 2004, despite the apparent increase in bowel 
conditions, the ongoing associated problems were actually lower than what would be 
expected. Given the increases in bowel surgery in the later cohort, the ongoing problems 
may be the result of continued constipation. Although parents report thyroid and bowel 
conditions as a current problem, they are most likely attributable to the necessity of 
continued treatment rather than the cause of a current medical condition. 
A high percentage (60%) of respiratory conditions was reported by parents in 2004. As 
respiratory infections are considered a leading cause for hospital admissions among 
children with Down syndrome [27] and are shown to be a major cause of mortality [28], 
this may be cause for concern. However, parental report showed low prevalences in 
current respiratory problems, and illnesses such as pneumonia and bronchitis were also 
reduced. Furthermore, respiratory conditions represented the greatest reduction in 
overnight hospital admissions and length of stay in 2004. These results demonstrate a 
possible improvement in the frequency and severity of respiratory conditions in school-
aged children with Down syndrome. Sleep apnoea was reported to occur in 20% of 
children with Down syndrome in the 2004 cohort. These prevalences were lower than 
other studies [29,30]. This may be due to the smaller sample sizes than in the present 
study, or that parents are reported to substantially underestimate the prevalence of sleep 
apnoea assuming that irregular breathing during sleep is normal for children with Down 
syndrome . As sleep apnoea may be associated with lower IQ performance [31] ,and 
behaviour problems [32] parents need to be informed of the prevalence of sleep apnoea 
and its associated implications. 
In 2004, musculoskeletal conditions, the majority of which were 'flat feet', occurred in 
35.6% of children with Down syndrome. 'Flat feet' is the most common musculoskeletal 
condition reported for children with Down syndrome [33] and is temporarily correctable 
with orthotics, worn by over half of the children with . flatfeet in our study sample. 
Although only a minor musculoskeletal impairment, early identification and correction 
should be provided to children with Down syndrome to prevent subsequent 
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biomechanical and postural problems [33]. However, a reduction in podiatry services 
were reported in 2004 indicating that children may no longer be receiving the level of 
specialist services they require. Atlantoaxial instability was diagnosed in 4.3% of 
children by cervical spine x-ray. These results are comparably lower than previous 
studies [34,35] However, these studies are relatively dated, and since their publication 
recommendations for routine screening for atlantoaxial instability have been revised such 
that routine screening is currently only indicated for children with Down syndrome who 
are symptomatic [36]. 
As previously mentioned, the use in GP services and combined specialist services were 
decreased in 2004 compared with the earlier cohort. Given the phasing out of specialist 
disability medical services at the Disability Services Commission in 2002, this trend is to 
be expected as specialist services may no longer be as accessible to families. Specialist 
services previously coordinated by the Disability Services Commission, for example 
audiologists, have shown reductions in service use, yet the conditions managed by these 
health professionals have increased, indicating the possibility that specialists services 
may not be as accessible to this population as they once were in 1997. With regards to 
the reduction in GP services, the general improvements in health of children with Down 
syndrome are likely to influence the frequency of GP service attendance. These 
reductions in GP service use, are a positive indicator that the general health of children 
with Down syndrome is improving. 
In 2004 school-aged children with Down syndrome were reported to have increased day 
admissions to hospital, while overnight hospital admissions were significantly reduced 
compared with 1997. Interestingly, these trends in hospitalisations mirror that of the 
general population of school-aged children. However, young children with Down 
syndrome demonstrated a greater decrease in overnight hospital admissions compared 
with the general population, which may be indicative of improvements in health for 
children with Down syndrome. 
The impact of socio-demographic factors on service use were outlined in this study and in 
places, showed an interesting contrast. Overnight hospital admissions and specialist 
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services use demonstrated divergent trends. While many socio-demographic factors 
impact on specialist services, few factors impact on overnight hospital admissions. The 
limited association of socio-demographic factors on overnight hospital admissions may 
demonstrate that overnight hospital admissions are not dependent on the socio-economic 
gradient and are equitable for all children. This contrasts with the findings relating to 
specialist service use which is greatly impacted on by socio-demographic factors. These 
results may provide an insight into the level of accessibility in specialist service use for 
families in Western Australia with a child with Down syndrome. However, some results 
presented were difficult to explain. For example, higher paternal education was 
associated with increased GP and specialist service use, while the lowest skill level for 
fathers also demonstrated increased rates of service use. Little explanation can be offered 
with regards to these findings, except that perhaps biases existed in the reporting of 
parents. Future research would be beneficial which analyses the impact of socio-
demographic factors on service use for children with Down syndrome based on 
government Medicare data. This would also provide a comparison between parental 
report and government data to understand biases which may exist in parental reporting. 
In interpreting the findings of this study several limitations should be acknowledged. As 
the data collection was based on a questionnaire, random recall error may have occurred 
whereby parents inaccurately recorded answers due to memory recall over time. In cases 
where there was missing data, results may be affected. Finally, the varied responses given 
by parents due to the differing terminology they may have used could have lead to 
possible encoding errors. However, although these limitations exist, this study provides a 
valuable insight into the changing health of children with Down syndrome and their 
service needs. To our knowledge, no other studies have described the changing health of 
children with Down syndrome over time. Furthermore, although limited research has 
described the increased medical service utilisation for children with Down syndrome 
[10-12], our study is unique in providing an insight into the changes in medical service 
use over time, and the impact" socio-demographic factors may have on service use, which 
until now have been unexplored. 
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The information provided in this study has important implications for parents, health care 
professionals and education providers. A clear understanding of the co-morbidities 
experience by children with Down syndrome and the knowledge that a reduction in 
ongoing cardiac problems and improved health has occurred over time, will assist parents 
in making informed decisions regarding future plans or possible terminations of 
pregnancy. This information is also valuable to health care professionals in providing 
effective programs and interventions suitable for each child's physical capacities and 
limitations which minimise disability and facilitate development, functioning and 
increase quality of life for children with Down syndrome. Finally, this research 
contributes to the knowledge of medical service utilisation by this population and may 
assist in the planning and provision of disability services in Western Australia. 
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Figure 1: The study process 
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Table I: Demographic characteristics of families in 2004 
Characteristics Families, N(%) 
within each category 
Parental Education 
High maternal education (post 62/202 (30.7) 
high school qualifications) 
Low maternal education 140/202 (69.3) 
(secondary education) 
High paternal education 44/200 (22.0) 
Low paternal education 156/200 (78.0) 
Fathers occupational skill level 
0 (Lowest skill level) 15/170 (8.8) 
1 28/170 (16.5) 
2 34/170 (20.0) 
3 29/170 (16.1) 
4 (Highest skill level) 64/170 (37.6) 
Maternal work status 
Working 97/195 (49.75) 
Not working 98/195 (50.25) 
Family income 
Below $20,000 34/208 (16.4) 
$20,000- $31,999 20/208 (9.6) 
$32,000-$51,999 37/208 (17.8) 
$ 52,000-$77,999 34/208 (16.4) 
$78,000 onwards 44/208 (21.1) 
Missing data 39/208 (18.8) 
Place of Residence 
Rural 164 (78.8) 
Metropolitan 44 (21.2) 
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Table II: Specific medical conditions in children with Down syndrome in 2004. 
Condition Children reported 
to have the 
condition N (%) 
Cardiac: any 95 (45.7) 
Ventricular septal defect 33 (15.9) 
Atrial septal defect 25 (12.0) 
A ventricular septal defect 16(7.7) 
'Hole in the heart' 11 (5.3) 
Patent ductus arteriosis 8 (3.9) 
Tetralogy ofFallot 2 (1.0) 
Bowel: any 66 (31.7) 
Constipation 41 (19.7) 
Duodenal atresia 9 (4.3) 
Coeliac disease 0 (0.0) 
Hirschsprung disease 0 (0.0) 
Ear or bearing: any 123 (59.1) 
Glue ear 86(41.3) 
Perforated ear drum 18 (8.7) 
Hearing loss 36 (17.3) 
Eye or visual: any 140 (67.3) 
Short sightedness 52 (25.0) 
Long sightedness 45 (21.6) 
Strabismus 49 (23.6) 
Astigmatism 18 (8.6) 
Nystagmus 9 (4.3) 
Cataracts 6 (2.9) 
Thyroid disease: any 26 (12.5) 
Hypothyroidism 22 (22.6) 
Hyperthyroidism 3 (1.4) 
Musculoskeletal 74 (35.6) 
Atlantoaxial instability 9 (4.33) 
Flat feet 47 (22.6) 
Scoliosis 5 (2.4) 
Perthes 3 (1.44) 
Respiratory 126 (60.0) 
Sleep apnoea 39 (19.8) 
Asthma 42 (20.2) 
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Table III: Medical conditions and episodic illnesses in school aged children with 
Down syndrome in 2004 compared with 1997. 
Condition Odds Ratio 95% Conf Interval Pvalue 
Cardiac 1.11 0.90 1.39 0.32 
Medical Bowel 1.68 1.16 2.45 0.01 
condition: Ear 1.13 0.81 1.56 0.47 
ever Eye 0.79 0.55 1.15 0.23 
Thyroid 1.08 0.69 1.70 0.73 
Current Cardiac 0.52 0.28 1.00 0.05 
problem Bowel 1.29 0.77 2.18 0.33 
associated Ear 1.06 0.74 1.53 0.73 
with medical Eye 0.84 0.60 1.18 0.31 
condition Thyroid 1.54 0.89 2.66 0.12 
Episodic illness IRR 95% Conf Interval Pvalue 
Frequency of Cold or flu 0.92 0.81 1.04 0.19 
episodic Tonsillitis 0.56 0.38 0.83 <0.001 
illnesses Pneumonia 0.90 0.31 2.57 0.84 
Bronchitis 0.80 0.52 1.23 0.32 
Ear infection 0.77 0.62 0.95 0.01 
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Table IV: The use of medical services in 2004 compared with 1997. 
Service IRR 95% Conf. Interval Pvalue 
GP service visits 0.91 0.83 1.00 0.05 
Specialist services combined 0.92 0.84 1.01 0.09 
Paediatrician 0.96 0.72 1.28 0.77 
Cardiologist 
- - -
ENT specialist 1.12 0.89 1.42 0.34 
Disability specialist 0.11 0.05 0.22 <0.001 
Eye specialist 0.97 0.76 1.22 0.77 
Audiologist 0.80 0.61 1.04 0.09 
Podiatrist 0.67 0.50 0.91 0.01 
Dentist 1.13 0.96 1.33 0.14 
Hospitalisations IRR 95% Conf. Interval Pvalue 
Day admissions 1.20 0.81 1.76 0.37 
Overnight admissions 0.60 0.37 0.96 0.03 
Nights in hospital per 0.33 0.24 0.44 <0.001 
admission 
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Table V: The effects ofsocio-demographic factors on service use for children with 
Down syndrome in Western Australia in 2004. 
GP service use IRR 95% conf. Interval Pvalue 
High maternal education 1.09 0.90 1.31 0.39 
High paternal education 3.33 2.52 4.41 <0.001 
Father's skill level 1 0.21 0.17 0.28 <0.001 
Father's skill level 2 0.14 0.10 0.18 <0.001 
Father's skill level 3 0.30 0.24 0.38 <0.001 
Father's skilllevel4 0.16 0.13 0.20 <0.001 
$20,000- $31,999 0.88 0.60 1.28 0.50 
$32,000-$51,999 0.86 0.63 1.19 0.38 
$ 52,000-$77,999 1.13 0.82 1.55 0.45 
$78,000 onwards 0.93 0.68 1.26 0.64 
Missing data 2.48 1.86 3.29 <0.001 
Metropolitan area 1.00 0.81 1.24 0.05 
Working mothers 0.62 0.53 0.73 <0.001 
Specialist service use 
High maternal education 1.18 0.98 1.42 0.09 
High paternal education 1.63 1.30 2.05 <0.001 
Father's skilllevell 0.59 0.44 0.79 <0.001 
Father's skilllevel2 0.63 0.47 0.84 0.002 
Father's skill level 3 0.66 0.49 0.89 0.006 
Father's skilllevel4 0.60 0.46 0.79 <0.001 
$20,000- $31,999 1.67 1.16 2.40 0.006 
$32,000- $51,999 1.80 1.31 2.48 <0.001 
$ 52,000-$77,999 1.21 0.86 1.69 0.28 
$78,000 onwards 1.20 0.87 1.66 0.28 
Missing data 1.24 0.88 1.74 0.21 
Metropolitan area 1.05 0.88 1.27 0.58 
Working mothers 0.85 0.72 0.99 0.04 
Overnight hospital 
admissions 
High maternal education 1.28 0.48 3.44 0.48 
High paternal education 0.99 0.29 3.34 0.98 
Father's skill level 1 0.44 0.12 1.65 0.22 
Father's skill level 2 0.32 0.08 1.26 0.10 
Father's skill level 3 0.15 0.03 0.833 0.03 
Father's skill level 4 0.29 0.08 0.99 0.49 
$20,000- $31,999 0.30 0.18 5.04 0.40 
$32,000-$51,999 0.49 0.07 3.72 0.49 
$ 52,000-$77,999 3.91 0.83 18.40 0.08 
$78,000 onwards 0.86 0.15 5.03 0.87 
Missing data 2.65 0.54 12.95 0.22 
Metropolitan area 1.39 0.56 3.44 0.48 
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Working mothers 0.76 0.34 1.69 0.50 
Hospital day admissions 
High maternal education 5.15 1.71 15.6 0.004 
High paternal education 1.90 0.83 4.38 0.13 
Father's skill level 1 0.23 0.08 0.63 0.004 
Father's skill level 2 0.49 0.21 1.17 0.12 
Father's skill level 3 0.30 0.11 0.81 0.02 
Father's skill level 4 0.28 0.12 0.66 0.004 
$20,000- $31,999 1.68 0.51 5.50 0.39 
$32,000- $51,999 2.15 0.72 6.44 0.17 
$ 52,000-$77,999 1.14 0.34 3.84 0.83 
$78,000 onwards 0.66 0.19 2.31 0.52 
Missing data 1.04 0.31 3.44 0.95 
Metropolitan area 0.96 0.47 1.95 0.91 
Working mothers 0.60 0.33 1.09 0.09 
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